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Edited by Hans EklundAbstract The Ras-related human GTPase Rab4a is involved in
the regulation of endocytosis through the sorting and recycling of
early endosomes. Towards further insight, we have determined
the three-dimensional crystal structure of human Rab4a in its
GppNHp-bound state to 1.6 A˚ resolution and in its GDP-bound
state to 1.8 A˚ resolution, respectively. Despite the similarity of
the overall structure with other Rab proteins, Rab4a displays sig-
niﬁcant diﬀerences. The structures are discussed with respect to
the recently determined structure of human Rab5a and its com-
plex with the Rab5-binding domain of the bivalent eﬀector
Rabaptin-5. The Rab4 speciﬁc residue His39 modulates the
nucleotide binding pocket giving rise to a reduced rate for nucle-
otide hydrolysis and exchange. In comparison to Rab5, Rab4a
has a diﬀerent GDP-bound conformation within switch 1 region
and displays shifts in position and orientation of the hydrophobic
triad. The observed diﬀerences at the S2–L3–S3 region represent
a new example of structural plasticity among Rab proteins and
may provide a structural basis to understand the diﬀerential
binding of similar eﬀector proteins.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Small GTPases termed Ypt in yeast and Rab in higher
eukaryotes are central regulators of discrete transport steps be-
tween subcellular compartments of eukaryotic cells along the
biosynthetic/secretory pathway, as well as the endocytic path-
ways [1–3]. Since each member of the Rab family has its par-
ticular function inside the cell, each Rab/Ypt protein is
localized at the membrane of speciﬁc intracellular compart-
ments and is highly speciﬁc for a particular transport stepAbbreviations: Rab, Ras-like protein from rat brain; Ypt, yeast protein
transport; Amp, Ampicillin; Carb, Carbenicillin; GppNHp, guanosine
5 0-O-(b-c-imido)-triphosphate; LB, Luria Bertani media
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doi:10.1016/j.febslet.2005.04.020[4]. Rab/Ypt proteins, like all Ras-related GTPases, act as
molecular switches by cycling between an inactive GDP-bound
(oﬀ-) state and an active GTP-bound (on-) state. Rab proteins
act in the GTP-bound state through the recruitment of speciﬁc
eﬀector proteins to the membrane on which they are localized
[2,5]. What is striking in the family of Rab proteins is the very
high speciﬁcity with respect to their target compartments and
their eﬀectors. This is in contrast to the high sequence homol-
ogy and similarity in the three-dimensional fold between the
members of this family. A recent extensive sequence-analysis
study of Rab proteins identiﬁed the presence of ﬁve Rab-fam-
ily speciﬁc amino acid stretches, termed RabF regions [6]. In
addition, four other regions, termed RabSF regions, have been
evidenced, which can be used to deﬁne ten subfamilies of Rab
GTPases [6]. In order to provide further insight into Rab spec-
iﬁcity, we have been focusing on the Rab4 subfamily. Members
of the Rab4 subfamily are involved in important physiological
processes. Thus, Rab4 was found to be associated with early
endosomes [7] playing a role in their sorting and recycling
[8]. Rab4 is also implicated in the regulation of the recycling
of internalized receptors back to the plasma membranes
[7,9–11]. Furthermore, Rab4 seems to have a specialized role
in receptor-mediated antigen processing in B-lymphocytes
[12], in calcium-induced a-granule secretion in platelets [13],
and in a-amylase exocytosis in exocrine pancreatic cells [14].
In addition, Rab4 appears to control the subcellular distribu-
tion of the glucose transporter isoform Glut4, speciﬁcally ex-
pressed in the insulin-sensitive adipose and muscle tissues
[15–17]. Therefore, it is assumed that Rab4 is implicated in
early endosome traﬃcking by controlling steps necessary for
sorting, recycling and degradation. In recent years, a number
of proteins that speciﬁcally bind to the GTP-bound form of
Rab4 have been identiﬁed by the yeast two-hybrid system
and by aﬃnity chromatography, such as Rabaptin-5 [18,19],
Rabaptin-5b [20], Rabaptin-4/5a [21,22], Rabenosyn-5 [23],
Rabip4 [24], Rabip4 0 [25], Rab coupling protein (RCP) [26],
Dynein light intermediate chain-1 [27], syntaxin 4 [28], and
CD2AP/CMS [29]. Most of the identiﬁed Rab eﬀectors are
divalent, interacting with more than one Rab protein. These
divalent eﬀector proteins might function as membrane-tether-
ing molecules [30,31]. In this respect, Rabaptin-5 and Rabeno-
syn-5 might physically connect entry and recycling sites on
early endosomes through the simultaneous interaction with
Rab4 and Rab5 [32]. Therefore, a detailed understanding of
the observed selectivity and discrimination towards eﬀector
proteins within the Rab protein subfamilies demands their
three-dimensional structures. In the present study, we report
the crystal structure at atomic level for the human Rab4ablished by Elsevier B.V. All rights reserved.
2822 S.K. Huber, A.J. Scheidig / FEBS Letters 579 (2005) 2821–2829protein in its GppNHp- and GDP-bound states, respectively.
Comparative analysis of these structures provide new insight
concerning the regions that display nucleotide-dependent con-
formations and which are thought to be responsible for the
Rab4a binding speciﬁcity.2. Materials and methods
2.1. Expression and puriﬁcation
For the crystallization and determination of the three-dimensional
structure of human Rab4a (GenBank Accession No. AF498934), ﬁve
diﬀerent constructs coding for residues 1–213 (wild-type), 1–210
(DC3), 1–198 (DC15), 1–184 (DC29), and 1–176 (DC37) were ampliﬁed
by PCR and inserted into a modiﬁed Escherichia coli expression vector
pET19TEV (Novagen). This vector adds a His6-sequence followed by
a tobacco etch virus (TEV) protease cleavage site to the N-terminus of
the recombinant protein. The expression plasmid was transformed
into E. coli strain BL21(DE3)RIL (Stratagene) and colonies were se-
lected on Luria Bertani (LB)-agarose plates with 100 lg/ml carbenicil-
lin. Recombinant protein expression from 5 l of LB media (100 lg/ml
ampicillin) was induced with 0.3 mM IPTG at OD600  0.7. Three
hours after induction at 30 C, the cells were harvested and resus-
pended in lysis buﬀer (25 mM Na-phosphate, pH 7.5, 300 mM NaCl,
2 mM 2-mercapto-ethanol, 1 mM MgCl2, 5% (v/v) glycerol, 1 mM
PMSF, 1 mM benzamidine, 100 lg DNase). Cells were disrupted
using a micro-ﬂuidizer (Microﬂuidics, MA, USA). After adding
0.1% (v/v) Tween-20 and stirring for 15 min, the lysate was cleared
by ultracentrifugation (60 min, 48 000 · g at 4 C). The supernatant
was loaded onto a Ni-NTA-agarose superﬂow column (Qiagen) equil-
ibrated with buﬀer A (25 mM Na-phosphate, pH 7.5, 300 mM NaCl,
2 mM 2-mercapto-ethanol, 1 mM MgCl2, 5% (v/v) glycerol). Elution
of the His-tagged protein was achieved with a linear gradient of 0–
500 mM imidazole. Fractions containing pure Rab4a, as revealed by
SDS–PAGE, were pooled, thoroughly dialyzed against buﬀer B
(50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1 mM MgCl2, 1 mM 2-
mercapto-ethanol) and concentrated using a Centriprep concentrator
with 10 kDa cutoﬀ (Amicon, Millipore) to about 10 mg/ml. For re-
moval of the N-terminal aﬃnity tag, TEV protease was added in a
molar ratio of 1:25 and the mixture was incubated at 4 C for 12 h.
TEV protease, aﬃnity tag and uncleaved Rab4a were removed by
passing the reaction mixture through 10 ml Ni-NTA-agarose. The
protein of interest was obtained in the ﬂowthrough and concentrated
using a Centriprep concentrator with 10 kDa cutoﬀ (Amicon, Milli-
pore) to about 20 mg/ml. Due to the TEV cleavage site, all Rab4a con-
structs contained two amino acids Gly-His upstream the start
methionine. For the ﬁnal puriﬁcation step, gel-ﬁltration chromatogra-
phy on Superdex 75, 16/60 column (Amersham Biosciences) equili-
brated with buﬀer B was performed. Nucleotide exchange was
performed as described [33].2.2. Crystallization
Crystallization trials with Hampton Research sparse-matrix screens
1 and 2 were performed at diﬀerent temperatures (12, 15, and 20 C) by
vapor diﬀusion using the hanging-drop technique in 24-well Linbro
plates (ICN). Crystallization droplets consisted of equal amounts
(2 ll) of protein solution (20–25 mg/ml) mixed with reservoir solution.
The reservoir volume was 500 ll. The Rab4a construct missing the last
29 residues (Rab4aDC29) could be well expressed and crystallized in
the GppNHp- and the GDP-bound form. After optimization of the
initial crystallization conditions, the best diﬀracting crystals for
Rab4aDC29 Æ GppNHp could be grown with a reservoir solution con-
sisting of 30% (w/v) PEG 8000 (Fluka), 200 mM ammonium sulfate
(Fluka) and 100 mM sodium cacodylate (Fluka) (pH 6.5). The volume
of the unit cell is consistent with four molecules in the asymmetric unit
and a solvent content of around 58%. Crystals of Rab4aDC29 Æ GDP
could be grown at 25 C from a reservoir solution consisting of 8%
(w/v) PEG 4000 (Fluka) and 100 mM sodium acetate (Fluka) (pH
4.0). The crystals grew in the C-centered monoclinic space group C2
with cell constants a = 71.1 A˚, b = 63.7 A˚, c = 38.3 A˚, and b = 100.
The volume of the unit cell is consistent with one molecule in the asym-
metric unit and a solvent content of around 42%.2.3. Data collection, structure determination and model analysis
Prior to ﬂash freezing in liquid nitrogen, the crystals of Rab4a-
DC29 Æ GDP were soaked for 1–5 min at 18 C in a cryo-protectant sta-
bilizer solution (containing 20–25% glycerol in reservoir solution)
whereas the crystals of Rab4aDC29 Æ GppNHp could be ﬂash frozen
without prior addition of further cryo-protectant. All data processing
and reduction were performed using the program package XDS/
XSCALE [34]. Data collection and processing statistics are given in
Table 1. The structure of Rab4aDC29 Æ GppNHp was solved by molec-
ular replacement with the program MOLREP [35] as implemented in
the CCP4 program package [36]. A homology model derived from
Rab5C Æ GppNHp (PDB-entry 1HUQ [37]) was used as search model
(calculated with the program MODELLER [38] without nucleotide,
magnesium and water molecules). A single molecular replacement
solution with four molecules of Rab4aDC29 Æ GppNHp per asymmet-
ric unit could be obtained. The structure of Rab4aDC29 Æ GDP was
solved by molecular replacement using the partially reﬁned model of
Rab4aDC29 Æ GppNHp without nucleotide, magnesium and water
molecules as a search model. A single molecular replacement solution
with one molecule of Rab4aDC29 Æ GDP per asymmetric unit could be
obtained. Reﬁnement was performed using the programs CNS [39] and
REFMAC5, as implemented in the CCP4 program package [36,40,41].
After each reﬁnement round, the model was checked and rebuilt
against rA-weighted maps; map display and model rebuilding was
done with the program O [42]. The ﬁnally reﬁned models include
residues 2–177 (molecule A), 3–175 (molecule B and D), and 2–175
(molecule C) for the GppNHp-complex and residues 4–180 for the
GDP-complex, lacking residues 38–41 (part of loop L2) and residues
67–77 (part of loop L4/5). In addition, the GppNHp structures include
one nucleotide and one magnesium ion per molecule, and four Tris,
two 2-mercaptoethanol and 680 water molecules in the asymmetric
unit. The GDP structure includes one nucleotide but no magnesium
ion, two glycerol and 208 water molecules. The individual statistics
for data collection, processing and reﬁnement are given in Table 1.
The pair-wise structural alignment of Rab4a with other Rab proteins
was performed with the program DaliLite [43]. Images were created
using the program PyMol version 0.97 [44].3. Results and discussion
3.1. The overall structure
Diﬀerent constructs with truncations in the hyper-variable C-
terminal peptide were tested for their propensity to crystallize in
both the active GppNHp-bound and the inactive GDP-bound
forms. The successful Rab4aDC29 construct had essentially
the same GTPase activity as the full-length protein (data not
shown). The overall structure of the truncated Rab4a (Figs.
1A,B and 2) possessed the typical G-domain fold of the proto-
typic small GTPase Ras [45,46], consisting of a core formed by a
six stranded b-sheet surrounded by ﬁve a-helices. Rab4aD-
C29 Æ GppNHp crystallizes in the tetragonal space group P43
with four molecules in the asymmetric unit. Within the four
molecules, the largest deviations are observed in the regions
of a-helix H1/loop L2 (residues 20–45), loop L4/a-helix H2
(residues 66–81) and of a-helix H3/loop L7 (residues 99–114),
and to a lesser extent in loop L3/b-strand S3 (residues 50–57)
(Fig. 1). These regions are not modulated by crystal packing
forces but display rather high temperature B-factors. It is fre-
quently observed that ﬂexible regions get ordered upon complex
formation and therefore, might indicate important epitops for
the binding of eﬀector proteins. Rab4aDC29 Æ GDP crystallizes
in the monoclinic space group C2 with one molecule in the
asymmetric unit. Due to disorder in the crystal, the ﬁrst ﬁve
amino acid residues, residues 35–43, and 181–184 could not
be traced in the electron density map. Furthermore, a Mg(II)-
ion coordinating the nucleotide in most other small GTP-bind-
ing proteins could not be identiﬁed (Fig. 3B).
Table 1
Data statistics for Rab4aDC29 Æ GppNHp and Rab4aDC29 Æ GDP
Data collection and processing GppNHp GDP
Beamline/area detector ESRF ID14-4/Q4R ADSC BESSY II BL1/MAR CCD
Temperature (K) 100 100
Wavelength (A˚) 1.008 1.0721
Space group P4(3) C2
Cell dimensions (A˚) a = b = 99.8, c = 95.5 a = 71.4, b = 63.7, c = 38.3, b = 100.1
Resolution limita (A˚) 32.0–1.6 (1.75–1.6) 18.29–1.8 (1.86–1.8)
Number of recorded reﬂections 842 789 67 696
Average redundancy 6.9 4.3
Rsym
a,b (%) 5.6 (24.9) 7.1 (19.9)
Average I/ra (I) 20.9 (6.7) 14.44 (7.5)
B-factor from Wilson plot (A˚2) 27.1 23.1
Reﬁnement statistics
Resolution range (A˚) 20.0–1.6 18.0–1.8
Number of unique reﬂections 128 819 15 669
Completeness of dataa (%) 99.5 (97.4) 99.8 (100.0)
Rwork
c/Rfree
d(%)a 19.2/22.6 (22.8/26.8) 15.8/18.9 (20.9/26.6)
Ramachandran plote A: 95, 5, 0 jB: 95, 5, 0j 92.8, 5.9, 1.3
Favored, allowed, generous (%) C: 95.6, 4.4, 0jD: 94.4, 5, 0.6
R.M.S.D. on bond lengths (A˚) 0.018 0.012
R.M.S.D. on bond angle () 1.851 1.501
Mean/R.M.S.D. on B-factors (A˚2)f
Backbone (AjBjCjD) 24.4/7.7j19.7/5.1 14.9/7.6
22.2/6.4j28.5/9.9
Side-chain (AjBjCjD) 28.1/9.3j23.9/8.3 18.5/9.6
25.9/8.7j32.4/12.0
Nucleotide (AjBjCjD) 22.4/2.8j16.8/1.8 13.1/2.5
17.8/1.6j22.3/2.5
Solvent 36.8/8.5 (680 water molecules) 29.4/8.4 (208 water molecules)
PDB ID 2BME 2BMD
aValues in parentheses are for the high-resolution bin.
bRsym ¼ 100
P
h
P
ijI iðhÞ  hI iðhÞij=
P
h
P
iI iðhÞ where Ii(h) is the ith measurement and ÆIi(h)æ is the mean of all measurements of I(h) for Miller
indices hk l.
cR ¼PðkF obsj  kjF calckÞ=
P jF obsj where Fobs and Fcalc are observed and calculated structure factor amplitudes, respectively.
dRfree value is the R value obtained for a test set of reﬂections, consisting of a randomly selected 5% subset of the diﬀraction data not used during
reﬁnement [71].
eCalculated using the program PROCHECK [72].
fFor Rab4a Æ GppNHp the values for each molecule (A, B, C, and D) in the asymmetric unit are given. Rab4a Æ GDP contains only one molecule per
asymmetric unit.
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Structures of several small GTPases and eﬀects of mutations
have been investigated over the last two decades [47]. Besides
their similar overall fold, these proteins share a number of con-
served structural motifs. Among them, the phosphate-binding
loop (P-loop), i.e. the GXXXXGK(S/T) motif (where X stands
for any amino acid residue), is found to play a crucial role in
GTP hydrolysis. In Rab4a, the P-loop consists of residues
15GNAGTGKS while in Rab5a of residues 27GESAVGKS.
Whereas Rab5 is characterized by a rather fast intrinsic
GTP-hydrolysis rate (k = 0.12 min1 at 37 C) compared to
other small GTPases [48,49], Rab4 has a 25-fold slower hydro-
lysis rate (k = 0.0046 min1 at 37 C) [21]. Mutational and
structural characterization of the Rab5a residues at position
29 and 30 [50–52] indicated that Rab5a-A30G had no detect-
able inﬂuence and Rab5a-S29A only slightly reduced the
intrinsic GTP-hydrolysis rate. Therefore, the signiﬁcant diﬀer-
ence in the intrinsic hydrolysis rate between Rab5a and Rab4a
cannot be explained solely by the sequence diﬀerences within
the P-loop and the inﬂuence of further residues has to be con-
sidered. In this respect, the superposition of the P-loop region
of Rab4a and Rab5a indicates a signiﬁcant diﬀerence in the
position of residue His39 of Rab4a and Ser51 of Rab5a. The
large side-chain of His39 reaches over the c-phosphate moietyof GppNHp in complex with Rab4 (Fig. 3C). Consequently, in
addition to its inﬂuence on the nucleotide exchange rate, it
might have an electrostatic eﬀect on the water environment,
thus reducing the GTP-hydrolysis rate. A similar contribution
was observed for Tyr37 of Rab7 [53], for Phe51 of Rab3a [54]
and for Gln20 of Rab6 [55].
3.3. Comparison of the GDP- and GppNHp-bound states
Comparison of all GDP- and GTP analogue-bound struc-
tures of small GTPases reveals mainly two diﬀerent types of
conformational changes. The most common one displays a dis-
placed and disordered switch 1 region [55–58]. The second type
of conformational change diﬀers from the ﬁrst category in the
formation of an additional b-strand formed by the displaced
loop of the switch 1 region. The latter is sometimes accompa-
nied by a relative shift between b-strands S2 and S3 which re-
sults in a displacement of the S2–L3–S3 segment [59–62]. In the
case of Rab4a, the loop of the switch 1 region (loop L2, resi-
dues Lys34 to Glu44) is not visible in the GDP-bound form
(Fig. 1B). The weak and very noisy electron density distribu-
tion cannot be explained by the formation of an additional
b-strand as it is observed for Rab5a [52]. Comparison of the
GppNHp-bound and the GDP-bound states of Rab4a reveals
signiﬁcant changes in the orientation of the three aromatic
Fig. 1. Stereo-representation of the main-chain trace of Rab4a. (A) Superposition of the four Rab4aDC29 Æ GppNHp molecules within the
asymmetric unit. The main-chain traces of the molecules are represented in diﬀerent colors. The nucleotides are displayed in stick representation; the
magnesium ions are shown in green spheres. Regions which display root-mean-square deviations (R.M.S.D.) larger than 0.75 A˚ (based on Ca-atom
positions) are loop L2, L4, a-helix H2, a-helix H3 and loop L7. The end of b-strand S2, loop L7 and the start of b-strand S3 display a R.M.S.D. of
around 0.4 A˚. (B) Superposition of the main-chain trace of Rab4a Æ GppNHp (in green) and Rab4a Æ GDP (in ochre). The switch 1 and 2 regions are
highlighted in red (Rab4a Æ GppNHp) and in blue (Rab4a Æ GDP). In Rab4a Æ GDP, the switch 1 region from residue 35–43 is not visible in the crystal
structure. The orientation is the same as in panel (A). The nucleotides GppNHp (green) and GDP (ochre) and the hydrophobic triad Phe45, Trp62,
and Tyr77 are displayed in stick representation.
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teins (Fig. 1B). Upon GTP-hydrolysis the hydrogen-bond be-
tween Gly66-N (loop L2) with the nucleotide c-phosphate is
lost. As a consequence, residues Arg69 and Phe70 adopt diﬀer-
ent orientations. In addition, the proximate helix H2 is shifted
and consequently Tyr77 is rearranged in its position. As a fur-
ther consequence, Trp62 displays a diﬀerent side-chain rot-
amer. Albeit the switch 1 region (loop L2, residues Lys34 to
Glu44) is not structured in the GDP-bound form, the third res-
idue of the hydrophobic triad, Phe45, adopts a position nearly
identical to the GppNHp-bound state (Fig. 1B). Additional
conformational diﬀerences between the two Rab4a complexes
may be noticed in the position of a-helix H2 due to the missing
interaction of loop L4 with the c-phosphate moiety. The diﬀer-ent packing of a-helix H2 inﬂuences the packing of the end of
a-helix H3 and the following loop L7. Although, these changes
do not produce major rearrangements of the overall architec-
ture, they are still large enough to perturb the shape of a puta-
tive eﬀector binding epitope on the Rab4a site.
3.4. Structural diﬀerences between Rab4a and related Rab
proteins
Rab4a has essentially the same main-chain trace as other
Rab/Ypt proteins including the glycine-induced bulge at the
end of the eﬀector loop, L2, ﬁrst described by Dumas et al.
[54]. As a consequence of the sequence diﬀerences (Fig. 2),
the conformational dissimilarities between the structure of
Rab4a and known structures of the other Rab proteins
Fig. 2. Sequence alignment between the human Rab proteins Rab3a, Rab4a, Rab5a, Rab5c, Rab6a, Rab9, Rab7a and Rab11. The sequence
alignment was performed with the program ClustalW [67], manually adjusted to ﬁt secondary structure elements based on analysis with the program
DaliLite [43]. The ﬁnal ﬁgure was prepared with the program ESPript [68] using the similarity score 0.7 0.5 B. The secondary structure elements for
the Rab4a Æ GppNHp structure were determined with the program DSSP [69] and are labeled according to the general fold of small GTP-binding
proteins. The Rab protein speciﬁc sequence regions RabF and RabSF [6] are superimposed on the sequence alignment. The red dots at the end of the
RabSF4 label indicate that this region extends till the C-terminal end of the full-length protein. The cyan underlayed residues in the Rab4a sequence
were removed in the crystallized construct (Rab4aDC29). The green triangles highlight those residues, which in the Rab5a–Rabaptin-5c complex were
observed to be in close contact to the eﬀector protein [62].
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icant (summarized in Table 2). Rab4 and Rab5 are both local-
ized at the early endosome and the plasma membrane and are
involved in opposite steps of membrane transport. Rabaptin-
5 is a divalent eﬀector with two diﬀerent, non-overlapping bind-
ing sites for Rab5 and Rab4 [63]. The Rab4-binding site of
Rabaptin-5 also has a coiled-coil propensity, but very little se-
quence similarity within the region that binds Rab5. A clear dis-
crimination between these two proteins is crucial for the
speciﬁcity of vesicular transport steps associated with early
endosomes. To date, there is no structural information avail-
able for complexes of Rab4a and its eﬀector proteins. However,
recently the ﬁrst eﬀector complex of human Rab5a with the
truncated C-terminal domain of Rabaptin-5 was determined
by protein crystallography [62]. This structure revealed signiﬁ-
cant diﬀerences to the Rab3a-Rabphilin complex [64] and the
comparable Arl1-GRIP complex [65]. Rab5a mainly interacts
with the eﬀector protein via its switch 2 region and the two b-
strands S2 and S3. The epitope comprises the Rab-speciﬁc gly-
cine buldge and the invariant hydrophobic triad, Phe57, Trp74
and Tyr89 (Fig. 4, numbering according to the sequence of hu-
man Rab5a). In addition, the Rab5a residues Thr59, Tyr82 and
Met88 are part of the eﬀector binding epitope. Based on the
high-resolution structure of Rab4 Æ GppNHp it is evident that
in concert with a slightly diﬀerent conformation of the hydro-phobic triade (Fig. 4), the residues Val43(Ala55), Phe70
(Tyr82), Val73(Leu), and S76(Met88) (parentheses refer to
the corresponding residue of Rab5) are building a signiﬁcantly
diﬀerent surface topology and charge distribution for the puta-
tive Rabaptin-binding site on Rab4a (Fig. 5A–C) and there-
fore, prevent binding of Rab4a to the Rab5a-binding site of
Rabaptin-5. This is especially important to the splice-variant
Rabaptin-5d, which does not contain a Rab4-binding site [63]
and only interacts with Rab5. To obtain well diﬀracting crystals
of Rab4a for both nucleotide complexes, we have used the C-
terminally truncated Rab4aDC29. Thus, we have no structural
information concerning the C-terminus of Rab4a. However,
the hydrolysis rate of this construct is similar to the one of
full-length protein. On the other hand, the strength of the inter-
action with the eﬀector protein Rabaptin-5 got weaker the more
residues were removed from the C-terminus of Rab4a (DC3,
DC15, DC29, and DC37 were tested; data not shown). This indi-
cates, in contrast to Rab5a, some inﬂuence of the C-terminus of
Rab4a on binding to Rabaptin-5. Sequence analysis of the
identiﬁed Rab4-binding domains of diﬀerent eﬀector proteins
do not signiﬁcantly indicate conserved residues within these
Rab4-binding domains. Therefore, it can be speculated that
the interface of the complex between Rab4 and Rab4-binding
domains is diﬀerent in size and position compared to the
Rab5a–Rabaptin-5 complex.
Fig. 3. Active site of Rab4a. Electron density distribution around the bound nucleotide in (A) Rab4a Æ GppNHp and (B) Rab4a Æ GDP. The rA-
weighted 2Fo–Fc electron density maps are contoured in blue with a contour level of 1.5r. (C) Stereo representation of the nucleotide binding cleft of
Rab4a Æ GppNHp (C-atoms in green) superimposed onto Rab5a Æ GppNHp (C-atoms in blue; PDB entry 1R2Q [52]). Water molecules associated
with the magnesium ion (in grey) are represented as spheres (in red for Rab4a and in blue for Rab5a). The labels highlight those residues which are
diﬀerent in both structures. The subscript (4 or 5) in the label indicates the corresponding protein (Rab4a or Rab5a).
Table 2
Regions of Rab4a, which display most signiﬁcant structural diﬀerences in comparison to related Rab proteins
Region Observed diﬀerences compared to . . . The Rab protein(s) Bound nucleotide
L2 Diﬀerent main-chain trace Rab3, Rab5 GppNHp
Main-chain trace from residues Lys34 to Glu44 not visible Rab5c GDP
No magnesium-ion bound to GDP Rab5, Rab6, Rab7 GDP
S2–L3–S3 Relative shift of around 2.4–2.7 A˚ Rab3a, Rab9, Rab11 GppNHp, GDP
L4-H2-L5 Diﬀerent main-chain trace Rab6 GDP
H2 Concerted shift of the hydrophobic triad by around 1.5 A˚. Rab5 GppNHp
Better structured helix Rab7, Rab11 GppNHp
Less structured helix Rab9 GDP
L7 Diﬀerent main-chain trace Rab3a GppNHp
Diﬀerent orientation due to the insertion of four residues in . . . Rab7, Rab9 GppNHp, GDP
L8 Diﬀerent conformation due to the insertion of one residue in Rab4a Rab7, Rab9 GppNHp, GDP
L9 Diﬀerent orientation due to the insertion of four residues in . . . Rab7 GppNHp, GDP
2826 S.K. Huber, A.J. Scheidig / FEBS Letters 579 (2005) 2821–2829In summary, structures of Rab4a-GDP and Rab4a-
GppNHp revealed diﬀerences in the nucleotide binding site
due to the side-chain conformation of the Rab4a residue
His39, small shifts in position and orientation of the hydro-
phobic triad (Rab4a F45-W62-Y77) together with diﬀerences
in the main-chain trace of the switch 1 region (L2) and theS2–L3–S3 region and represent a new example of structural
plasticity among Rab proteins. The observed diﬀerences, as
compared to other Rab proteins, are small but cannot be pre-
dicted by homology modeling. However, they are large enough
to be of signiﬁcance for speciﬁc recognition by cognate eﬀector
proteins.
Fig. 4. Stereo-representation of the main-chain traces of superimposed Rab4a Æ GppNHp (in green) and Rab5a Æ GppNHp (in blue). The orientation
is similar to Fig. 1. In addition to the hydrophobic triad those residues are labeled which are diﬀerent in type or orientation between Rab4a and
Rab5a. The subscript (4 and 5, respectively) in the label indicates the corresponding protein. The displayed side-chain diﬀerences are the same for all
four subunits in the asymmetric unit of the Rab4DC29 Æ GppNHp structure.
Fig. 5. Representation of the molecular surface of Rab5a Æ GppNHp and Rab4a Æ GppNHp, respectively. (A) Mapping of the eleven residues of
Rab5a forming the binding epitope for Rabaptin-5c [62]. The molecular surface of Rab5a Æ GppNHp is colored in green and the region of interaction
is highlighted in red. (B + C) The electrostatic surface potential of Rab5a Æ GppNHp (B) and of Rab4a Æ GppNHp (C) reveals a striking diﬀerence in
surface topology and charge distribution within and around the putative binding region. The electrostatic potential (blue, positive; red, negative
charge) was calculated with the program APBS [70] and represented with the program PyMOL [44].
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